Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Providence Health & Services
ClinicalTrials.gov Identifier:
NCT01644968
First received: July 17, 2012
Last updated: July 18, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2015
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
No publications provided by Providence Health & Services

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):